ATE253378T1 - Xenogene transplantation - Google Patents

Xenogene transplantation

Info

Publication number
ATE253378T1
ATE253378T1 AT94918019T AT94918019T ATE253378T1 AT E253378 T1 ATE253378 T1 AT E253378T1 AT 94918019 T AT94918019 T AT 94918019T AT 94918019 T AT94918019 T AT 94918019T AT E253378 T1 ATE253378 T1 AT E253378T1
Authority
AT
Austria
Prior art keywords
administering
short course
xenogene
transplantation
methods
Prior art date
Application number
AT94918019T
Other languages
English (en)
Inventor
David H Sachs
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Priority claimed from PCT/US1994/005527 external-priority patent/WO1994026289A1/en
Application granted granted Critical
Publication of ATE253378T1 publication Critical patent/ATE253378T1/de

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94918019T 1993-05-17 1994-05-16 Xenogene transplantation ATE253378T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6317193A 1993-05-17 1993-05-17
US12960893A 1993-09-29 1993-09-29
US18155894A 1994-01-12 1994-01-12
US22037194A 1994-03-29 1994-03-29
PCT/US1994/005527 WO1994026289A1 (en) 1992-02-19 1994-05-16 Allogeneic and xenogeneic transplantation

Publications (1)

Publication Number Publication Date
ATE253378T1 true ATE253378T1 (de) 2003-11-15

Family

ID=27490346

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99121033T ATE283063T1 (de) 1993-05-17 1994-05-16 Allogene und xenogene transplantation
AT94918019T ATE253378T1 (de) 1993-05-17 1994-05-16 Xenogene transplantation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99121033T ATE283063T1 (de) 1993-05-17 1994-05-16 Allogene und xenogene transplantation

Country Status (6)

Country Link
EP (1) EP0699073B1 (de)
JP (2) JPH09500616A (de)
AT (2) ATE283063T1 (de)
AU (1) AU688330B2 (de)
CA (1) CA2162496A1 (de)
DE (2) DE69433298T2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993009815A1 (en) * 1991-11-22 1993-05-27 The General Hospital Corporation Specific tolerance in transplantation
WO1995021527A1 (en) * 1994-02-14 1995-08-17 The General Hospital Corporation Stem cell engraftment

Also Published As

Publication number Publication date
JP2006312647A (ja) 2006-11-16
AU688330B2 (en) 1998-03-12
CA2162496A1 (en) 1994-11-24
DE69433298D1 (de) 2003-12-11
JPH09500616A (ja) 1997-01-21
DE69434159D1 (de) 2004-12-30
HK1029512A1 (en) 2001-04-06
EP0699073A4 (de) 1997-09-10
DE69434159T2 (de) 2005-12-01
AU6952194A (en) 1994-12-12
EP0699073A1 (de) 1996-03-06
ATE283063T1 (de) 2004-12-15
DE69433298T2 (de) 2004-08-26
EP0699073B1 (de) 2003-11-05

Similar Documents

Publication Publication Date Title
ATE395418T1 (de) Alpha(1,3)galactosyltransferase-negatives schwein
GR3036778T3 (en) -i(IN VITRO) CORNEA EQUIVALENT MODEL.
GR3036548T3 (en) Apparatus and method for preparing solid forms with controlled release of the active ingredient
ATE193550T1 (de) Rekonstruiertes knorpelgewebe
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
NO942351D0 (de)
FI972093A0 (fi) Jäteveden käsittelymenetelmä ja -laitos
DK0868505T3 (da) Chondrogen in vitro induktion af humane mesenchymstamceller
IS4100A (is) Aðferð við meðhöndlun á ígræðlingi úr málmi fyrirskurðaðgerð
DK0912106T3 (da) Middel til forøgelse af produktionen af/opdræt og produktion af pattedyr
DE69431107D1 (de) Die erzeugung von toleranz gegen fremdtransplantate durch tolerogenese mit hilfe von ersatzlebewesen
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
SE9003718D0 (sv) Implantat med genomgaaende passage
IL158384A0 (en) Treatment or prophylaxis of insulin producing cell graft rejection
DE3865044D1 (de) Mittelohr-prothese.
ATE464910T1 (de) Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung
ATE275968T1 (de) Mitteln zur behandlung von auto-immun krankheiten
DK0768886T3 (da) Endothelforingseffekter og behandling af vasospastiske lidelser
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE146967T1 (de) Verwendung von ifn-gamma zur behandlung von infektionen bei transplantatenempfängern
ATE283063T1 (de) Allogene und xenogene transplantation
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
DK0745071T3 (da) 4-Amino-6-substitueret mycophenolsyre og derivater med immunsuppressiv virkning
EP0444899A3 (en) Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties